WeVote

Bill

Bill

SB 1344

newborn screening program

57th Legislature - First Regular Session Introduced by T.J. Shope

Arizona modifies newborn screening requirements to alter disease detection protocols and procedures for testing infants for genetic and metabolic disorders.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · SB 1344

Legislative bill overview

SB 1344 modifies Arizona's newborn screening program, which tests infants for serious genetic, metabolic, and functional disorders shortly after birth. The bill adjusts screening requirements, procedures, or the panel of conditions tested, though specific substantive changes require review of the bill text itself.

Why is this important

Newborn screening programs are critical public health infrastructure—early detection of conditions like sickle cell disease, cystic fibrosis, or metabolic disorders enables immediate treatment that prevents severe disability or death. Changes to screening protocols directly affect which conditions are caught early and how families access results and follow-up care.

Potential points of contention

  • Scope of screening panel: Whether the bill expands or limits which conditions are screened; expanding costs more but catches more disorders; limiting saves money but may miss treatable conditions
  • Parental consent and notification: Questions about informed consent procedures, opt-out provisions, and how quickly parents receive results
  • Program funding and implementation: Whether changes require additional state funding or create administrative burdens on hospitals and laboratories conducting tests

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.